News & Updates

Among patients with interstitial lung disease, cough-specific quality of life (QOL) is independently associated with adverse outcomes, specifically respiratory hospitalization, death, and lung transplantation, as reported in a study.

Treatment with benralizumab significantly reduces exacerbation rates in patients with asthma in a real-world setting, according to the ZEPHYR 2 study presented at AAAAI 2022.

Not only does tezepelumab reduce asthma symptomatic days, it prevents asthma exacerbations across all seasons in adolescents and adults with severe, uncontrolled asthma, according to the prespecified exploratory analyses of the NAVIGATOR trial presented at AAAAI 2022.

Meteorological and environmental factors may be used as early warning signals for wheezing diseases and respiratory virus prevalence in children, a recent China study has found.

Older men with high levels of serum folate seem to be more likely to have better pulmonary function, reports a recent Korea study.

A novel gut microbiota–derived synbiotic formula known as SIM01 is an effective adjuvant therapy for coronavirus disease 2019 (COVID-19), which hastens antibody formation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reduces nasopharyngeal viral load, reduces proinflammatory immune markers, and restores gut dysbiosis in COVID-19 patients, researchers from the Chinese University of Hong Kong (CUHK) have reported.